Home > Insider Trading > Filing (0001415889-24-022620)

Filing Details

Accession Number:: 0001415889-24-022620
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-30 16:04:43
Reporting Period:: 2024-08-28

Accepted Time:: 2024-08-30 16:04:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1831828	Vera Therapeutics Inc.	VERA	Pharmaceutical Preparations (2834)	812744449

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1859453	Marshall Fordyce	C/O Vera Therapeutics, Inc. 8000 Marina Boulevard, Suite 120 Brisbane CA 94005	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2024-08-28	14,925	$2.90	337,592	No	4	M	Direct
Class A Common Stock	Disposition	2024-08-28	14,925	$36.80	322,667	No	4	S	Direct
Class A Common Stock	Acquisiton	2024-08-28	700	$2.90	323,367	No	4	M	Direct
Class A Common Stock	Disposition	2024-08-28	700	$37.54	322,667	No	4	S	Direct
Class A Common Stock	Disposition	2024-08-28	13,995	$36.82	308,672	No	4	S	Direct
Class A Common Stock	Disposition	2024-08-28	700	$37.53	307,972	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Option (Right to Buy)	Disposition	2024-08-28	15,625	$0.00	15,625	$2.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
842,962		2030-12-15	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 23, 2024.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.46 to $37.42, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.59, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.46 to $37.44, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.61, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.